ALLMedicine™ Chronic Obstructive Pulmonary Disease Center

Dec 3rd, 2020 - Exacerbation of chronic obstructive pulmonary disease (COPD) severely impacts the quality of life and causes high mortality and morbidity. COPD is involved with systemic and pulmonary inflammation, which may be attenuated with antidiabetic agents ...

Dec 3rd, 2020 - Estimates for lung function decline in chronic obstructive pulmonary disease (COPD) have differed by study setting and have not been described in a UK primary care population. To describe rates of FEV1 and FVC decline in COPD and investigate chara...

Dec 3rd, 2020 - The pharmacology of roflumilast, recent dosing revisions, and the integral roles of pharmacists in effective chronic obstructive pulmonary disease (COPD) management are reviewed here. COPD is characterized by progressive airflow limitation and int...

Dec 3rd, 2020 - To compare the therapeutic effects of high-flow-oxygen-Therapy (HFT) and noninvasive-ventilation (NIV) for stabilizing chronic obstructive pulmonary disease during exacerbation. In this randomized clinical trial at Masih-Daneshvari hospital, betwe...

Dec 3rd, 2020 - Pulmonary hypertension (PHT) is one of the essential predictors of mortality in chronic obstructive pulmonary disease (COPD). It is thought that PHT is due to vasoconstriction secondary to hypoxia caused by airway obstruction in COPD patients; how...

Mar 14th, 2020 - Approximately 1% to 4% of all visits to primary care offices are for dyspnea.1 The proper use of pulmonary function tests can help differentiate many of the causes of dyspnea, monitor the progression of chronic pulmonary disease, and assess respon...

Feb 16th, 2020 - Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder in which patients are at high risk for both pulmonary and systemic complications of their disease. Medical nutrition therapy by a registered dietitian nutritionist can be ...

Oct 19th, 2019 - Observational studies suggest that beta-blockers may reduce the risk of exacerbations and death in patients with moderate or severe chronic obstructive pulmonary disease (COPD), but these findings have not been confirmed in randomized trials.

Sep 30th, 2019 - To assess the relationship between muscular strength measures and mortality in outpatient populations with chronic diseases such as cancer, chronic obstructive pulmonary disease, renal disease, and metabolic and vascular diseases, and in criticall...

May 23rd, 2019 - Chronic obstructive pulmonary disease (COPD; including chronic bronchitis and emphysema) is a chronic respiratory condition characterised by shortness of breath, cough and recurrent exacerbations. Long‐term antibiotic use may reduce both bacterial...

Dec 3rd, 2020 - Exacerbation of chronic obstructive pulmonary disease (COPD) severely impacts the quality of life and causes high mortality and morbidity. COPD is involved with systemic and pulmonary inflammation, which may be attenuated with antidiabetic agents ...

Dec 3rd, 2020 - Estimates for lung function decline in chronic obstructive pulmonary disease (COPD) have differed by study setting and have not been described in a UK primary care population. To describe rates of FEV1 and FVC decline in COPD and investigate chara...

Dec 3rd, 2020 - The pharmacology of roflumilast, recent dosing revisions, and the integral roles of pharmacists in effective chronic obstructive pulmonary disease (COPD) management are reviewed here. COPD is characterized by progressive airflow limitation and int...

Dec 3rd, 2020 - To compare the therapeutic effects of high-flow-oxygen-Therapy (HFT) and noninvasive-ventilation (NIV) for stabilizing chronic obstructive pulmonary disease during exacerbation. In this randomized clinical trial at Masih-Daneshvari hospital, betwe...

Dec 3rd, 2020 - Pulmonary hypertension (PHT) is one of the essential predictors of mortality in chronic obstructive pulmonary disease (COPD). It is thought that PHT is due to vasoconstriction secondary to hypoxia caused by airway obstruction in COPD patients; how...

Nov 10th, 2020 - With this week's announcement that Pfizer's vaccine candidate against SARS-CoV-2 was 90% effective in preventing COVID-19, the world is one step closer to an effective vaccine. Nevertheless, with a limited supply of initial doses, the question bec...

Nov 2nd, 2020 - A digital healthcare app called MyCOPD could help individuals with chronic obstructive pulmonary disease (COPD) to recover faster after hospital admission and decrease re-exacerbation of symptoms, suggests a new study published in the  NPJ Digital...

Nov 2nd, 2020 - A digital healthcare app called MyCOPD could help individuals with chronic obstructive pulmonary disease (COPD) to recover faster after hospital admission and decrease re-exacerbation of symptoms, suggests a new study published in the  NPJ Digital...

Oct 27th, 2020 - NEW YORK (Reuters Health) - Using prescription oral cannabinoid drugs is associated with increased rates of adverse outcomes in older patients with chronic obstructive pulmonary disease (COPD), a new study shows. COPD patients increasingly use pre...

Oct 27th, 2020 - NEW YORK (Reuters Health) - Using prescription oral cannabinoid drugs is associated with increased rates of adverse outcomes in older patients with chronic obstructive pulmonary disease (COPD), a new study shows. COPD patients increasingly use pre...